Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)Charles S. Fuchs, Robert J. Mayer, Donna Niedzwiecki et al.|Journal of Clinical Oncology|2017Cited by 137
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter StudyPatrick Cheung, Georg A. Bjarnason, Samir Patel et al.|European Urology|2021Cited by 128
Sites of metastasis and survival in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).Shaan Dudani, Daniel Yick Chin Heng, Guillermo de Velasco et al.|Journal of Clinical Oncology|2020Cited by 31
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trialGeorg A. Bjarnason, Naveen S. Basappa, Jennifer J. Knox et al.|European Journal of Cancer|2019Cited by 28
An in-depth multicentered population-based analysis of outcomes of patients with metastatic renal cell carcinoma (mRCC) that do not meet eligibility criteria for clinical trials.Daniel Yick Chin Heng, Lori Wood, Mary J. MacKenzie et al.|Journal of Clinical Oncology|2012Cited by 18